7803-58-9 | Sulfamide

Packsize	Purity	Availability	Price	Discounted Price
10g	97%	in stock	$12.00	$9.00
25g	97%	in stock	$15.00	$11.00
100g	97%	in stock	$47.00	$33.00
500g	97%	in stock	$67.00	$47.00

Description

• Catalog Number: AB79249
• Chemical Name: Sulfamide
• CAS Number: 7803-58-9
• Molecular Formula: H4N2O2S
• Molecular Weight: 96.1090
• MDL Number: MFCD00011606
• SMILES: NS(=O)(=O)N
• NSC Number: 252

Computed Properties

• Complexity: 85.3
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 5
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 2
• XLogP3: -1.7

Literature

• Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine.

  Bioorganic & medicinal chemistry 20130601

• Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.

  Bioorganic & medicinal chemistry letters 20120901

• Anion inhibition studies of an α-carbonic anhydrase from the living fossil Astrosclera willeyana.

  Bioorganic & medicinal chemistry letters 20120201

• Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.

  Bioorganic & medicinal chemistry letters 20110615

• Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.

  Bioorganic & medicinal chemistry 20110315

• Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.

  Bioorganic & medicinal chemistry letters 20110115

• Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives?

  Bioorganic & medicinal chemistry 20110101

• Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV.

  Bioorganic & medicinal chemistry letters 20100615

• Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the pathogenic yeast Candida glabrata with anions.

  Bioorganic & medicinal chemistry letters 20090815

• Carbonic anhydrase inhibitors: the membrane-associated isoform XV is highly inhibited by inorganic anions.

  Bioorganic & medicinal chemistry letters 20090215

• Carbonic anhydrase inhibitors: inhibition studies of a coral secretory isoform with inorganic anions.

  Bioorganic & medicinal chemistry letters 20090201

• Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with anions.

  Bioorganic & medicinal chemistry letters 20081215

• Carbonic anhydrase inhibitors: inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with simple anions.

  Bioorganic & medicinal chemistry letters 20080915

• Carbonic anhydrase inhibitors: the inhibition profiles of the human mitochondrial isoforms VA and VB with anions are very different.

  Bioorganic & medicinal chemistry 20071101

• Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions.

  Bioorganic & medicinal chemistry letters 20070315

• Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions.

  Bioorganic & medicinal chemistry letters 20070215

• Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions.

  Bioorganic & medicinal chemistry letters 20060615

• Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.

  Bioorganic & medicinal chemistry letters 20050502

• Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.

  Bioorganic & medicinal chemistry letters 20050201

• Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.

  Bioorganic & medicinal chemistry letters 20041220

• Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.

  Bioorganic & medicinal chemistry letters 20041206

• Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions.

  Bioorganic & medicinal chemistry letters 20041101

• Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions.

  Bioorganic & medicinal chemistry letters 20040906

• Carbonic anhydrase inhibitors: inhibition of cytosolic isozymes I and II with sulfamide derivatives.

  Bioorganic & medicinal chemistry letters 20030310

• Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.

  Bioorganic & medicinal chemistry letters 20030310